Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Polysaccharide K (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 06 Jun 2016 Status changed from active, no longer recruiting to completed.
- 21 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Jan 2011 Planned end date changed from 1 Jun 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.